SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000921895-23-002360
Filing Date
2023-10-23
Accepted
2023-10-23 15:07:26
Documents
1
Period of Report
2023-10-12

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT form313531001_10232023.html 3  
1 OWNERSHIP DOCUMENT form313531001_10232023.xml 3 2309
  Complete submission text file 0000921895-23-002360.txt   3776
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 6502444990
TITAN PHARMACEUTICALS INC (Issuer) CIK: 0000910267 (see all company filings)

IRS No.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O TITAN PHARMACEUTICALS, INC. 400 OYSTER POINT BLVD., SUITE 505 SOUTH SAN FRANCISCO CA 90480
Business Address
Chiam Brynner (Reporting) CIK: 0001998335 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-13341 | Film No.: 231339883